Last updated: June 19, 2024
Sponsor: HaEmek Medical Center, Israel
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Clindamycin
Metronidazole
Clinical Study ID
NCT01722708
0012-12-EMC
Ages 18-50 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Pregnant women at increased risk for preterm labor (preterm cervical effacement,preterm uterine contractions, twins pregnancy, vaginal bleeding, past pretermdelivery)
Age above 18 years
Exclusion
Exclusion Criteria:
Known allergy to the tested antibiotics
Antibacterial treatment in the week before the vaginal culture was taken
preterm premature rupture of membranes
Study Design
Total Participants: 750
Treatment Group(s): 2
Primary Treatment: Clindamycin
Phase:
Study Start date:
November 01, 2012
Estimated Completion Date:
August 01, 2025
Connect with a study center
Departement of obstetric and gynecology, HaEmek medical center
Afula,
IsraelActive - Recruiting
Departement of obstetric and gynecology, Poriya Medical Center
Tiberias,
IsraelActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.